Glaxo Shifts Rx Resveratrol Focus But Nutritional Interest Still Strong
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline's decision to abandon its pharmaceutical research program on resveratrol leaves the red wine extract exclusively to the nutritionals industry.
You may also be interested in...
National Advertising Division In Brief
Unilever's superior moisture claim upheld
New Products In Brief
DSM's resveratrol raises the bar: Rancho Santa Fe, Calif.-based ResVez Inc. launches Winetime Bar, a chocolate nutrition bar with "as much resveratrol as 50 glasses of red wine," the company says Dec. 1. Winetime contains DSM Nutritional Products' resVida trans-resveratrol ingredient, which ResVez says "comes with the most extensive scientific and safety substantiation in the marketplace." Winetime, also containing super fruits such as noni and mangosteen, sells through ResVez's Web site at $29.90 for 10 bars or $89.70 for 40 bars, plus shipping
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.